Jai Narain Vishwakarma

Jai Narain Vishwakarma


Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 January 2016 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
SKShunan Kaping
Shunan Kaping
UKUtpalparna Kalita
Utpalparna Kalita
MSMelboureen Sunn
Melboureen Sunn
LSLaishram Indira Singha
Laishram Indira Singha
JVJai Narain Vishwakarma
Jai Narain Vishwakarma

28 October 2015 in Molecular Diversity
Verified
Journal Article
Closed access
PDF file
SKShunan Kaping
Shunan Kaping
IBIvee Boiss
Ivee Boiss
LSLaishram Indira Singha
Laishram Indira Singha
PHPhilippe Helissey
Philippe Helissey
JVJai Narain Vishwakarma
Jai Narain Vishwakarma


18 May 2021 in Monatshefte für Chemie - Chemical Monthly
Verified
Journal Article
Closed access
PDF file
SKShilpika Khanikar
Shilpika Khanikar
SKShunan Kaping
Shunan Kaping
PHPhilippe Helissey
Philippe Helissey
PJPrince Joshi
Prince Joshi
SSSalique Hassan Shaham
Salique Hassan Shaham
JVJai Narain Vishwakarma
Jai Narain Vishwakarma

1 July 2004 in Journal of Heterocyclic Chemistry
Verified
Journal Article
Closed access
PDF file
KCKaushik Chanda
Kaushik Chanda
MDMilan Ch. Dutta
Milan Ch. Dutta
EKEnamul Karim
Enamul Karim
JVJai Narain Vishwakarma
Jai Narain Vishwakarma

31 March 2020 in European Journal of Chemistry
Verified
Journal Article
Open access
PDF file
SKShunan Kaping
Shunan Kaping
MSMelboureen Sunn
Melboureen Sunn
ILIndira S Laishram
Indira S Laishram
JVJai Narain Vishwakarma
Jai Narain Vishwakarma
A series of antipyrinyl-pyrazolo[1,5-a]pyrimidines have been synthesized by reactions of aminopyrazole (4) with various formylated active proton compounds in the presence of KHSO4 (aqueous media), under ultrasound irradiation. The structures of the compounds have been established with the help of spectral and analytical data. N-(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-7-phenylpyrazolo[1,5-a]pyrimidine-3-carboxamide (6a) was further subjected to X-ray crystallographic studies to avoid any ambiguity of the derived structures. Crystal data for compound 6a, C51H46N12O5 (M =907.00 g/mol): triclinic, space group P-1 (no. 2), a = 9.9554(3) Å, b = 14.0875(4) Å, c = 17.4572(4) Å, α = 79.676(2)°, β = 85.283(2)°, γ = 72.647(2)°, V = 2297.97(11) Å3, Z = 2, T = 296.15 K, μ(MoKα) = 0.088 mm-1, Dcalc = 1.311 g/cm3, 29732 reflections measured (4.174° ≤ 2Θ ≤ 57.068°), 10681 unique (Rint = 0.0400, Rsigma = 0.0533) which were used in all calculations. The final R1 was 0.0566 (I > 2σ(I)) and wR2 was 0.1663 (all data). The novel compounds were also screened for their biological activities.